catalyst

Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Mu — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2014-08-21 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Mu — primary completion
Type
Trial Readout
Date
2014-08-21
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here
trial
Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238)
trial